NCBI Logo
GEO Logo
   NCBI > GEO > Accession DisplayHelp Not logged in | LoginHelp
GEO help: Mouse over screen elements for information.
          Go
Series GSE7011 Query DataSets for GSE7011
Status Public on May 01, 2008
Title Leukemia fusion-gene transduced human cord blood cells
Organism Homo sapiens
Experiment type Expression profiling by array
Summary MLL-AF9 expression in normal human umbilical cord blood CD34+ cells leads to long-term proliferation of a myeloid progenitor cell with leukemogenic potential. Expression of a Core Binding Factor leukemia fusion (AML1-ETO or CBFbeta-SMMHC) in human CD34+ cells results in self-renewal of primitive progenitor cells with multilineage potential and stem cell ability, but these cells do not induce leukemia in immunodeficient mice. This comparative microarray study was initiated to determine how faithful these cell cultures are to the transcriptome of patient samples expressing each of these different fusion proteins, and to analyze the signaling pathways that are unique to CBF cultures and MLL-fusion cultures, with the hope of determining why the MLL-fusion cells are leukemogenic while the CBF cells are not.
Keywords: Disease state analysis; comparison of leukemia fusion gene expression in normal human hematopoietic progenitor cells
 
Overall design We have established a culture system whereby we retrovirally transduce human CD34+ cells, obtained from cord blood, with the leukemia fusion genes MLL-AF9 (MA9), AML1-ETO (AE) or CBFbetaMYH11 (CM). Cells expressing each of these fusion proteins are able to proliferate long-term in vitro in a cytokine dependent manner. These cultures resemble somewhat the blast samples from patients that contain these different fusion proteins, in that MA9 cells are predominantly monocytic (M5-like), AE cells have a large population of primitive CD34+ cells with continued abnormal differentiation (M2-like) and CM cells also contain a population of primitive CD34+ cells with continued abnormal differentiation but also have a significant population of abnormal eosinophils (M4Eo). We grow these cells in the presence of fetal bovine serum (FBS), and also grow them in serum-free conditions using the BIT supplement from Stem Cell Technologies. For the current experiments we used cell cultures that had been proliferating in vitro for 8-12 weeks, in either serum-free conditions or with FBS. Replicate samples were included in some instances, and the same clonal cultures that were grown under either BIT or FBS were also included.
 
Contributor(s) Wei J, Wunderlich M, Jansen M, Fox C, Mulloy J, DiMartino J, Krejci O, Gu Y, Wilhelm J, Alvarez S, Cigudosa J
Citation(s) 18538732
Submission date Feb 12, 2007
Last update date Mar 25, 2019
Contact name James Mulloy
E-mail(s) james.mulloy@cchmc.org
Phone (513) 636-1844
Fax 513-636-3768
URL http://www.cincinnatichildrens.org/research/div/exp-hematology/labs/genotox/mulloy/
Organization name Cincinnati Children's Hospital Research Foundation
Department Experimental Hematology
Lab ML7013
Street address 3333 Burnet Ave
City Cincinnati
State/province OH
ZIP/Postal code 45229
Country USA
 
Platforms (1)
GPL570 [HG-U133_Plus_2] Affymetrix Human Genome U133 Plus 2.0 Array
Samples (18)
GSM161803 AML1-ETO expressing cord blood cell, clone 18, grown serum-free, replicate 1
GSM161804 AML1-ETO expressing cord blood cell, clone 18, grown serum-free, replicate 2
GSM161805 AML1-ETO expressing cord blood cell, clone 17, grown serum-free, replicate 1
Relations
BioProject PRJNA98353

Download family Format
SOFT formatted family file(s) SOFTHelp
MINiML formatted family file(s) MINiMLHelp
Series Matrix File(s) TXTHelp

Supplementary file Size Download File type/resource
GSE7011_RAW.tar 89.6 Mb (http)(custom) TAR (of CEL)

| NLM | NIH | GEO Help | Disclaimer | Accessibility |
NCBI Home NCBI Search NCBI SiteMap